Abstract
The relation between the kidney and vitamin D is well known. Vitamin D has also been recognized to regulate endocrine pancreatic function; it stimulates pancreatic beta cells proliferation and insulin secretion. And several studies suggest that vitamin D status may have a significant role in glucose homeostasis in general, and on the pathophysiology and progression of metabolic syndrome and type-2 diabetes in particular. The deficiency in vitamin D is associated with a reduced insulin secretion, which might be an important factor for the susceptibility of developing diabetes. Vitamin D has been proposed also as a possible therapeutic agent in the prevention and treatment of type-1 and type-2 diabetes. In diabetic patients at various CKD stages, circulating 25(OH)D levels are negatively correlated with glycosylated hemoglobin (HbA1c) values, which suggests that increasing circulating vitamin levels may have a beneficial effect of the glycemic control. Likewise, the activation of the vitamin D receptor (VDR) can reduce proteinuria and contribute to the nephroprotection. Low circulating 25(OH)D levels in CKD patients have been associated with a higher risk of all-cause mortality and faster progression of kidney disease. Unfortunately, the level of evidence to support 25(OH)D therapy for CKD or diabetes mellitus is low. Several studies of nutritional vitamin D supplementation in patients with CKD and type-2 diabetes are actually ongoing, although their results are not yet available.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aragno M, Mastrocola R, Medana C, Catalano MG, Vercellinatto I, Danni O, Boccuzzi G. Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes. Endocrinology. 2006;147(12):5967–74.
Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, Zhang Y, Yeghiazarians Y, Gardner DG. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation. 2011;124(17):1838–47.
Bas A, Lopez I, Perez J, Rodriguez M, Aguilera-Tejero E. Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res. 2006;21(3):484–90.
Tanaka Y, Tran PO, Harmon J, Robertson RP. A role for glutathione peroxidase in protecting pancreatic beta cells against oxidative stress in a model of glucose toxicity. Proc Natl Acad Sci U S A. 2002;99(19):12363–8.
Assalin HB, Rafacho BP, dos Santos PP, et al. Impact of the length of vitamin D deficiency on cardiac remodeling. Circ Heart Fail. 2013;6:809–16.
Takiishi T, Gysemans C, Bouillon R, et al. Vitamin D and diabetes. Rheumatol Dis Clin N Am. 2012;38:179–206.
Aguado P, Del Campo MT, Garcés MV, González Casaús ML, Coya J, Torrijos A, Bernad M, Gijón-Baños J, Martín Mola E, Martinez ME. Low Vitamin D levels in outpatient postmenopausal women in the Madrid area of Spain: its relationship with bone mineral density. Osteoporos Int. 2000;11:739–44.
Gonzalez Parra E, Aceña A, Lorenzo O, Tarín N, Gonzalez Casaus ML, Cristobal C, Huelmos A, Mahillo I, Pello AM, Carda R, Hernandez-Gonzalez I, Alonso J; Rodriguez Artalejo F, Lopez-bescos L, Ortiz A, Egido J, Tuñon J. Important abnormalities of bone and mineral metabolism are present in patients with coronary artery disease with mild decrease in stimated glomerulat filtratio rate. J Bone Miner Metab. 2015; in press.
Lopez ER, Regula K, Pani MA, Krause M, Usadel KH, Badenhoop K. CYP27B1 polimorphism variants are associated with type 1 diabetes mellitus n Germans. J Steroid Biochem Mol Biol. 2004;89-90:155–7.
Mohr SB, Garland CF, Gorham ED, Garland FC. The association between ultraviolet irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia. 2008;51:1391–8.
Raab J, Giannopoulou EZ, Schneider S, Warncke K, Krasmann M, Winkler C, Ziegler AG. Prevalence of vitamin D deficiency in pre-type 1 diabetes and its association with disease progression. Diabetologia. 2014. doi:10.1007/s00125-014-3181-4.
Joergensen C, Hovind P, Schmedes A, Parving HH, Rossing P. Vitamin D levels, microvascular complications, and mortality in type 1 diabetes. Diabetes Care. 2011;34:1081–5.
Mattila C, Knekt P, Mannistö S, Rissanen H, Laaksonen MA, Montonen J, et al. Serum 25-hydroxivitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care. 2007;30:2560–70.
Valdivielso JM, Fernandez E. Vitamin D receptor polymorphism and disease. Clin Chim ACta. 2006;37:1–12.
Clemente Postigo M, Muñoz Garach A, Serrano M, Garrido Sanchez L, Bernal Lopez MR, Fernandez Garcia D, Moreno Santos I, Garriga N, Castellano Castillo D, et al. Serum 25-hydroxyvitamin D and adispose tissue vitamin D receptor gene expression: relationship with obesity and type 2 diabetes. J Clin Endocrinol Metab. 2015;100(4):E 591–5.
Giulietti A, Gysemans C, Stoffels K, van Etten E, Decallone B, Overbergh L. Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia. 2004;47:451–62.
Vitamin D supplement in early childhood and risk for type 1 (insulin-dependent) diabetes mellitus. The EURODIAB Su-study 2 Study group. Diabetologia. 1999;42: 51–4.
George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med. 2012;29:e142–50.
Gonzalez-Parra E, Rojas-Rivera J, Tuñón J, Praga M, Ortiz A, Egido J. Vitamin D receptor activation and cardiovascular disease. Nephrol Dial Transplant. 2012;27 Suppl 4:iv17–21.
González-Parra E, Egido J. Vitamin D, metabolic syndrome and diabetes mellitus. Med Clin (Barcelona). 2014;142(11):493–6. 6.
Egido J, Ruiz-Ortega M, González Parra E, Rico Zalba L, Fernández Fernández B, Mallavia B, Ortiz A, Gómez Guerrero C. Tratamiento de la nefropatía diabética: más allá del bloqueo del sistema renina-angiotensina. Nefrol Sup Ext. 2011;2(5):77–84.
Rojas-Rivera J, de la Piedra C, Ramos A, Ortiz A, Egido J. The expanding spectrum of biological actions of vitamin D. Nephrol Dial Transplant. 2010;25:2850–65.
Fernández-Juárez G, Luño J, Barrio V, García de Vinuesa S, Praga M, Goicoechea M, Lahera V, Casas L, Oliva J, on behalf of the PRONEDI Study Group. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system. Clin J Am Soc Nephrol. 2013;8:1870–6.
González-Parra E, Avila PJ, Mahillo-Fernández I, Lentisco C, Gracia C, Egido J, Ortiz A. High prevalence of winter 25-hydroxyvitamin D deficiency despite supplementation according to guidelines for hemodialysis patients. Clin Exp Nephrol. 2012;16(6):945–51.
De Boer IH, Tinker LF, Connelly S, et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the women’s health initiative. Diabetes Care. 2008;31(4):701–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
González Parra, E., González-Casaus, M.L., Villa-Bellosta, R. (2016). Vitamin D and Diabetes in Chronic Kidney Disease. In: Ureña Torres, P., Cozzolino, M., Vervloet, M. (eds) Vitamin D in Chronic Kidney Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-32507-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-32507-1_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32505-7
Online ISBN: 978-3-319-32507-1
eBook Packages: MedicineMedicine (R0)